2012-000793-30: International Study for Treatment of Standard Risk Childhood Relapsed Acute Lymphoblastic Leukemia 2010 |
|
|
| Completed | 3 | 1242 | Europe, RoW | Epratuzumab, IMMU-103, Solution for infusion, ENDOXAN 200 mg ENDOXAN 500 mg ENDOXAN 1 g, CYTOSAR 100 mg CYTOSAR 500 mg CYTOSAR 1 g, Fortecortin, Etoposid, Zavedos, HOLOXAN, Puri-Nethol, METHOTREXAT, Mitoxantron, Oncaspar, Lanvis, Vincristine, Vindesine, Methotrexate, Methotrexat, CYTOSAR | Charité - University Hospital of Berlin, Manchester University NHS Foundation Trust, Turku University Hospital, EU Project FP7, Deutsche Kinderkrebsstiftung, Immunomedics, Deutsche kinderkrebsstiftung, Turku UNiversity Hospital | Acute lymphoblastic leukemia (ALL), Acute lymphoblastic leukemia (ALL), Diseases [C] - Cancer [C04] | | | | |
